These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM. Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588 [Abstract] [Full Text] [Related]
11. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC. J Pharmacol Exp Ther; 2007 Apr 03; 321(1):213-20. PubMed ID: 17202401 [Abstract] [Full Text] [Related]
15. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure. Scolletta S, Biagioli B. Biomed Pharmacother; 2010 Mar 03; 64(3):203-7. PubMed ID: 19954925 [Abstract] [Full Text] [Related]
19. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Dyck JR, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M, Kawase Y, Jishage K, Lopaschuk GD. Circulation; 2006 Oct 17; 114(16):1721-8. PubMed ID: 17030679 [Abstract] [Full Text] [Related]